Labcorp Launches Labcorp Global Trial Connect

Labcorp Launches Labcorp Global Trial Connect

By
Luisa Martinez
2 min read

Labcorp Launches Labcorp Global Trial Connect to Accelerate Clinical Trials

Labcorp, a US-based laboratory services company, has unveiled Labcorp Global Trial Connect, a comprehensive suite of central laboratory solutions aimed at expediting clinical trials, particularly at investigator sites. The suite incorporates digital and data offerings tailored to enhance trial efficiency, reduce data delays, and streamline workflows at investigator sites. It is accessible to existing Labcorp Central Laboratory clients and is designed to expedite the commencement of clinical trials, maintain study momentum, and improve trial throughput.

The features of Labcorp Global Trial Connect comprise resources for site enablement, support for supply readiness, facilitation of site workflows, and comprehensive study management and investigator support. These resources are intended to identify new trial opportunities, expand patient access and recruitment, and foster diversity in trials. The support services for supply readiness aim to boost study start-up efficiencies while minimizing trial delays and the wastage of supplies and kits.

Key Takeaways

  • Labcorp launches Labcorp Global Trial Connect, a suite of central laboratory solutions to expedite clinical trials.
  • The suite aims to enhance trial efficiency, reduce data delays, and streamline investigator site workflows.
  • Labcorp Global Trial Connect includes site enablement resources to expand patient access and promote diversity in trials.
  • The suite facilitates site workflows through integrated sample collection, data tracking, and eRequisition functionality to reduce errors.
  • Labcorp's Global Trial Connect offers 24/7 site support and on-demand tools to expedite study start-up and sustain trial momentum.

Analysis

Labcorp's Global Trial Connect has the potential to significantly impact the clinical trial landscape by enhancing efficiency and reducing delays. This initiative could accelerate drug development timelines, benefiting biopharma sponsors and potentially reducing healthcare costs. The focus on site enablement and patient diversity may broaden trial participation, crucial for robust data collection. In the short term, this could streamline trial operations, while long-term, it might standardize and improve clinical trial processes globally. The 24/7 support and integrated tools indicate a strategic shift towards more responsive and flexible trial management, potentially setting a new industry standard.

Did You Know?

  • Labcorp Global Trial Connect: A suite of central laboratory solutions introduced by Labcorp, aimed at accelerating clinical trials by improving trial efficiency, reducing data delays, and streamlining workflows at investigator sites. This suite integrates digital and data offerings to enhance trial throughput and support the start and momentum of clinical trials.
  • eRequisition functionality: A feature within Labcorp Global Trial Connect that automates the requisition process for sample collection in clinical trials. This functionality reduces errors, queries, holds, and data revisions by ensuring accurate and timely data tracking and sample collection, thereby enhancing the overall efficiency of the trial process.
  • Decentralized clinical trials: A method of conducting clinical trials that moves some trial activities away from centralized locations to more convenient settings, such as local clinics or even participants' homes. This approach aims to increase patient accessibility and diversity in trials by reducing geographical barriers and improving participant convenience. Labcorp's partnership with Hawthorne Effect supports this method, enhancing the flexibility and reach of clinical trials.

You May Also Like

This article is submitted by our user under the News Submission Rules and Guidelines. The cover photo is computer generated art for illustrative purposes only; not indicative of factual content. If you believe this article infringes upon copyright rights, please do not hesitate to report it by sending an email to us. Your vigilance and cooperation are invaluable in helping us maintain a respectful and legally compliant community.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings